All News

Patients who did not have health care coverage were found to have a significantly higher mean HbA1c levels among adults with diabetes.

Study evaluates the effect of long-acting monoclonal antibodies tixagevimab and cilgavimab treating COVID-19 symptoms and viral shedding.

Hospitalization costs from respiratory syncytial virus infection are driven by older age and comorbidities.

Precision medicine is rooted in the reality that the way patients respond to treatment is heavily affected by their individual genetic variability, their complex biology, and external factors.

Low compensation, stressful environment spark technician exodus; replacing them has been difficult.

Since the 2018 guideline’s publication, additional non-statin therapies such as bempedoic acid, evinacumab, and inclisiran, have been approved by the FDA for the management of hypercholesterolemia.

Diagnosing risk of frailty in patients hospitalized with heart failure is a safe and effective means of improving patient management.

Treatment-emergent adverse events were reported in a similar proportion of participants with recurrent Clostridioides difficile infection, both with and without immunocompromising conditions.

Approximately 56.6% of young adults with advanced heart disease prefer to be involved in end-of-life decisions if they were very ill, with nearly all patients saying that they would also like their parents to be involved.

Investigators of the phase 2 study also found a comparable reactogenicity to the individual influenza and COVID-19 vaccines from Novavax or authorized vaccine comparators.

Options abound, but pharmacists should address barriers to prevent inequities for patients when they seek treatment.

Routinely celebrating their work contributions and dedication adds value to your organization.

Patients with HIV were no less likely to show a worse clinical presentation following tecovirimat treatment.

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access.

Brexpiprazole was associated with a statistically and clinically meaningful improvement in agitative behaviors caused by dementia compared to placebo.

Nonprescription products manage mild to moderate symptoms, but more severe cases need further medical evaluation.

Harsha Rajasimha, PhD, discusses current challenges leading to clinical trial delays, such as the “valley of death.”

Although this should be a relatively routine process, the national conversations around abortion and contraception have brought more attention to the decision.

BI 456906 activates the GLP-1 and glucagon receptors that help to control metabolic function, and could potentially offer clinically relevant benefits for those living with obesity or overweight without type 2 diabetes.

Lili Wang, MD, PhD, discusses her research investigating how METTL3 regulates RNA splicing dysregulation and contributes to CLL growth.

Study shows that the nervous system of individuals experiencing post-COVID-19 fatigue is underactive in 3 key areas.

Investigators found that providing parents with a hypothetical scenario outlining why they should immunize their children against COVID-19 was effective in improving vaccination rates.

With a growing expectation for individualized and personalized care, medically integrated pharmacies have a great opportunity to support patients and the care team.

Atogepant reduced mean monthly migraine days by more than 2 days compared to placebo in the ELEVATE trial.

Anthony Pudlo, PharmD, MBA, executive director of the Tennessee Pharmacists Association, discusses his presentation at the National Association of Chain Drug Stores (NACDS) 2023 Regional Chain conference.

A new FDA policy would assess blood donor eligibility using a set of individual risk-based questions to reduce the risk of transfusion-transmitted HIV.

This treatment approach helps reduce symptoms and future exacerbations triggered by dust mites, pet dander, pollen.

Health systems must address drivers of attrition, turnover.